The Insurance Gap in Physical Therapy: Access, Use, and Out-of-Pocket Cost
Insurance status is one of many determinants of access to health care in the United States, yet its specific relationship to physical therapy access, utilization, and out-of-pocket cost has not been systematically synthesized. A narrative literature review was conducted to describe what is known about how insurance status affects these outcomes among adults in the United States. PubMed and the first 200 results of a Google Scholar search were utilized using terms combining physical therapy, insurance type, and access or utilization, restricted to English-language studies conducted in the United States and published between 2014 and 2026. Studies were included if they reported an original primary finding on physical therapy access, utilization, or out-of-pocket cost by insurance type in an adult population. Fifteen studies met inclusion criteria after two rounds of screening and were assigned to at least one of three themes: access, utilization, and out-of-pocket cost. Across the included studies, insurance status was most consistently associated with whether adults could access physical therapy at all. Mock-patient audits found that roughly 51 to 53 percent of practices accepted Medicaid compared with 94 to 97 percent for private insurance, a gap that was shown in both expansion and non-expansion states. Studies of treatment initiation similarly found lower rates among Medicaid-insured adults. Evidence on utilization once care began was more mixed with missed-appointment rates being higher among Medicaid-insured patients in both studies that measured them, while findings on session volume were inconsistent across payer types and study designs. Cost evidence was the most limited, as available data suggested that utilization management restrictions, including visit limits and referral requirements, may represent barriers alongside per-visit copayments. Insurance-related disparities in physical therapy appear to concentrate at the point of entry into care rather than within ongoing treatment. Provider contracting and reimbursement are likely drivers, and expanding eligibility alone does not appear sufficient to close the gap. Future research should include patient-level cost data, provider supply measures, and cohort designs that follow patients from referral through treatment completion.
Authors
- Jody Su
Publication Details
- Published
- 2026-11-19
- DOI
- https://doi.org/10.51224/sportrxiv.1180
- Primary Topic
- Healthcare Policy and Management
- Type
- preprint